Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of IV Ascorbic Acid (Ascor L 500) in Healthy Volunteers
NCT02534753Phase 1Completed
- Sponsor
- McGuff Pharmaceuticals
- Start
- Sep 2015
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Ascor L 500 in scurvy, sponsored by McGuff Pharmaceuticals. Primary endpoint: Concentration of Ascorbic Acid in plasma at 1 day. Started Sep 2015; status: completed.
02
Drugs
Ascor L 500
03
Conditions
scurvy
Beyond the preview
Go deeper on NCT02534753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02534753.